image
Healthcare - Biotechnology - NASDAQ - US
$ 2.99
-5.08 %
$ 96.3 M
Market Cap
-7.67
P/E
CASH FLOW STATEMENT
-7.34 M OPERATING CASH FLOW
-18.13%
4.28 M INVESTING CASH FLOW
176.33%
3.42 M FINANCING CASH FLOW
833.06%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Anixa Biosciences, Inc.
image
Net Income -12.7 M
Depreciation & Amortization 37 K
Capital Expenditures 0
Stock-Based Compensation 4.42 M
Change in Working Capital 526 K
Others 490 K
Free Cash Flow -7.34 M

Cash Flow

Millions
Oct-2024 Oct-2023 Oct-2022 Oct-2021 Oct-2020 Oct-2019 Oct-2018 Oct-2017 Oct-2016 Oct-2015 Oct-2014 Oct-2013 Oct-2012 Oct-2011 Oct-2010 Oct-2009 Oct-2008 Oct-2007 Oct-2006 Oct-2005 Oct-2004 Oct-2003 Oct-2002 Oct-2001 Oct-2000 Oct-1999 Oct-1998 Oct-1997 Oct-1996 Oct-1995 Oct-1994 Oct-1993 Oct-1992 Oct-1991 Oct-1990 Oct-1989
OPERATING CASH FLOW
Net Income (12.7) (9.9) (13.8) (13.1) (10.1) (11.8) (14.2) (5.0) (5.0) (1.4) (9.6) (10.1) (4.3) (7.4) (5.2) (16.5) (3.2) (5.5) (7.6) (4.5) (3.4) (3.1) (3.3) (3.6) (5.0) (8.5) (7.1) (5.8) (5.4) (3.0) (3.4) (2.8) (1.8) (1.3) (1.1) (1.1)
Depreciation & Amortization 37 K 46 K 42 K 59.9 K 90.2 K 0.5 0.3 0.4 0.4 0.3 0.3 1.0 7.23 K 7.98 K 8.36 K 10.6 K 0 9.89 K 15.1 K 14.7 K 0 33.1 K 86.5 K 0.2 0.3 0.3 0.3 0.3 100 K 100 K 100 K 0 0 0 100 K 100 K
Deferred Income Tax 0 0 0 0 0 0 0.6 45.9 K 0 0 3.4 61.9 K 0.1 30.2 K 5.2 9.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 4.4 4.4 6.0 7.5 3.9 5.7 8.9 1.2 0.9 2.7 3.1 3.8 0.7 2.7 2.7 5.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 0.4 0.3 0.8 5.45 K 0.1 0.4 15 K (0.8) 0.6 0.6 1.4 1.4 1.0 1.8 (5.1) 9.47 K 1.6 3.0 5.3 2.6 0 1.9 4.5 1.6 0.3 1.8 0.7 0.3 100 K (2.7) 100 K 0 0 0 (4.0) (3.9)
Change in Working Capital 0.5 (1.1) 0.5 78.5 K (0.5) 0.5 67.7 K 0.4 (0.2) (0.9) (1.0) 0.6 (0.8) 2.2 64.6 K (0.3) 0.8 53.5 K 0.4 0.1 2.2 0.3 (1.7) 1.1 (0.5) 0.3 (1.6) (5.0) 1.0 2.7 (0.2) 0.2 100 K 100 K 3.9 3.9
Cash From Operations (7.3) (6.2) (6.5) (4.9) (6.2) (4.7) (4.3) (3.8) (3.4) 1.4 (2.4) (3.2) (3.1) (0.7) (2.4) (2.5) (0.9) (2.4) (1.8) (1.7) (1.2) (1.0) (0.4) (0.7) (4.8) (6.1) (7.7) (10.2) (4.2) (2.9) (3.6) (2.6) (1.7) (1.2) (1.1) (1.0)
INVESTING CASH FLOW
Capital Expenditures 0 0 0 0 15.8 K (0.2) 38.4 K 30.2 K (0.1) 54.8 K 6.68 K 0 1.6 K 9.03 K 2.07 K 1.94 K 13.9 K 13.5 K 11 K 3.75 K 15.6 K 980 38.6 K 16 K 30.7 K 0 (0.2) (0.4) (0.4) 100 K 100 K 100 K 100 K 0 0 0
Other Items 4.3 (5.6) (10.7) (3.9) (0.3) (0.3) 1.5 (2.7) 1.6 100 K (2.5) 0.5 1.7 (2.1) 0.8 1.5 (18.0) (0.4) 0.3 (0.4) 0 0 0 96.9 K 0.4 (0.5) 1.0 (1.0) (0.9) (0.4) 0 0 0 1.9 100 K (1.8)
Cash From Investing Activities 4.3 (5.6) (10.7) (3.9) (0.3) (0.5) 1.5 (2.7) 1.5 45.2 K (2.5) 0.5 1.7 (2.1) 0.8 1.5 (18.0) (0.4) 0.2 (0.4) 15.6 K 980 38.6 K 80.9 K 0.4 (0.5) 0.8 (1.4) (1.3) (0.5) 100 K 100 K 100 K 1.9 100 K (1.8)
FINANCING CASH FLOW
Common Stock Repurchased 6 K 0 0 0 0 0 0 (0.5) 11.8 K (0.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0 0 0 0 0 3.3 1.8 0.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 851 13.5 K 33.5 K 68.2 K 29.5 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.5 0.4 0.5 0.4 0.1 0.2 58.1 K 6.9 2.68 K 44.6 K 0.4 1.5 0.2 1.3 1.3 2.0 2.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 K 0 0 0
Cash From Financing Activities 3.4 0.4 0.5 31.6 9.4 5.7 2.5 7.4 2.68 K (0.4) 7.3 3.2 1.0 2.5 1.2 2.0 18.7 2.2 2.4 1.6 1.2 1.1 8 K 0.8 4.0 2.8 0 1.8 18.8 6.0 1.6 6.9 1.7 1.4 1.1 3.3
CHANGE IN CASH
Net Change In Cash 0.4 (11.4) (16.8) 22.7 2.9 0.4 (0.3) 0.9 (1.9) 1.0 2.5 0.6 (0.4) (0.3) (0.4) 1.0 (0.2) (0.6) 0.8 (0.5) 20.8 K 0.2 (0.5) 0.2 (0.5) (3.8) (6.9) (9.8) 13.3 2.6 (2.1) 4.2 100 K 2.1 100 K 0.5
FREE CASH FLOW
Free Cash Flow (7.3) (6.2) (6.5) (4.9) (6.2) (4.9) (4.3) (3.8) (3.5) 1.3 (2.4) (3.2) (3.1) (0.7) (2.4) (2.5) (0.9) (2.4) (1.9) (1.7) (1.2) (1.0) (0.5) (0.7) (4.9) (6.1) (7.9) (10.6) (4.6) (3.0) (3.7) (2.7) (1.8) (1.2) (1.1) (1.0)